Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.21291
PubMed Identifier: 29212194
Publication URI: http://europepmc.org/abstract/MED/29212194
Type: Journal Article/Review
Volume: 8
Parent Publication: Oncotarget
Issue: 55
ISSN: 1949-2553